Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Board Changes

15 Jun 2022 11:06

RNS Number : 9787O
JLEN Environmental Assets Group Ltd
15 June 2022
 

15 June 2022

JLEN Environmental Assets Group Limited

 

Board Changes

 

The Board of JLEN Environmental Assets Group Limited ("JLEN" or the "Company") announces that Richard Morse has confirmed his intention to step down as non-Executive Chair of the Company, effective 15 July 2022, having served as a Director of the Company for nearly nine years.

 

The recruitment process for Richard's successor as Chair is in advanced stages and the Directors look forward to announcing the conclusion shortly. The Board would like to thank Richard for his commitment and dedication to the Company since its launch, and to wish him every success for the future.

 

Richard Ramsay, Senior Independent Director, said:

 

"We are grateful to Richard for his time and effort whilst on the Board of JLEN. As one of the Company's founding Directors, Richard has been instrumental in shaping the Board and driving effective governance through his collegiate and thoughtful leadership."

 

 

For further information please contact:

 

Foresight Group

Chris Tanner

Chris Holmes

 

+44(0)20 3667 8100

Winterflood Investment Trusts 

Neil Langford

Chris Mills

+44(0)20 3100 0000

 

SEC Newgate

Elisabeth Cowell

 

+44(0)20 3757 6882

 

Sanne Fund Services 

Matt Falla

Gemma Woods 

+44(0)1481 755530

 

About JLEN

JLEN's investment policy is to invest in a diversified portfolio of Environmental Infrastructure. Environmental Infrastructure is defined by the Company as infrastructure assets, projects and asset-backed businesses that utilise natural or waste resources or support more environmentally friendly approaches to economic activity, support the transition to a low carbon economy or which mitigate the effects of climate change. Such investments will typically feature one or more of the following characteristics:

 

· long-term, predictable cash flows, which may be wholly or partially inflation-linked cash flows;

· long-term contracts or stable and well-proven regulatory and legal frameworks; or

· well-established technologies, and demonstrable operational performance

 

JLEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly and to preserve the capital value of the portfolio over the long term on a real basis. The target dividend for the year to 31 March 2023 is 7.14 pence per share1. The dividend is payable quarterly.

 

Further details of the Company can be found on its website www.jlen.com

 

LEI: 213800JWJN54TFBMBI68

 

(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKPBKKBKDNAD
Date   Source Headline
23rd Mar 20217:00 amRNSAcquisition
8th Mar 202111:22 amRNSResult of EGM
3rd Mar 20217:00 amRNSAcquisition
24th Feb 20217:00 amRNSNotice of Capital Markets Day
16th Feb 202112:28 pmRNSUpdate research from QuotedData
16th Feb 20217:00 amRNSPublication of Shareholder Circular, Notice of EGM
15th Feb 202110:09 amRNSDirector Declaration
12th Feb 20217:00 amRNSNet Asset Value and Dividend Declaration
4th Feb 20217:00 amRNSAcquisition
4th Dec 20201:17 pmRNSAcquisition
26th Nov 20207:00 amRNSHalf-year Results, Dividend Declaration
27th Oct 20207:00 amRNSNotice of Results
18th Sep 20207:00 amRNSAcquisition
15th Sep 20206:00 pmRNSHolding(s) in Company
3rd Sep 20202:22 pmRNSResult of AGM and Directorate Change
18th Aug 20207:00 amRNSNet Asset Value and Dividend Declaration
7th Aug 20204:38 pmRNSDirector Declaration
30th Jun 20205:12 pmRNSNotice of AGM
11th Jun 20204:25 pmRNSDirectorate Change
11th Jun 20207:00 amRNSAnnual Financial Report
28th May 20207:00 amRNSNet Asset Value and Dividend
14th May 202011:16 amRNSUpdate research from QuotedData
7th May 20207:00 amRNSNotice of Results
2nd Apr 20207:00 amRNSAcquisition
1st Apr 20208:06 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20202:11 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Feb 20207:00 amRNSResult of Placing
13th Feb 20209:33 amRNSHolding(s) in Company
11th Feb 20207:02 amRNSRestructuring of Investment Advisory Arrangements
11th Feb 20207:00 amRNSProposed Placing
29th Jan 20207:00 amRNSNet Asset Value and Dividend Declaration
28th Jan 20207:00 amRNSPartnership Commitment
13th Dec 20197:00 amRNSAcquisition
4th Dec 20195:44 pmRNSHolding(s) in Company
21st Nov 20197:00 amRNSHalf-year Results, Dividend Declaration
17th Oct 20197:00 amRNSNotice of Results
10th Sep 20197:45 amRNSUpdate research from QuotedData
29th Aug 20192:36 pmRNSHolding(s) in Company
29th Aug 20197:00 amRNSAcquisition
15th Aug 20197:00 amRNSNet Asset Value and Dividend Declaration
14th Aug 20194:22 pmRNSResult of AGM & Change of Company Name
19th Jul 20197:00 amRNSAcquisition
5th Jul 20195:05 pmRNSNotice of AGM
1st Jul 20192:51 pmRNSChange of Adviser
13th Jun 20197:00 amRNSAnnual Financial Report
5th Jun 20197:00 amRNSProposed Change of Investment Adviser
30th May 20197:00 amRNSNet Asset Value and Dividend Declaration
20th May 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.